Method of treating psoriasis using an IL-17 receptor antibody formulation
US10072085B2 · kind B2 · utility
1Cited by
32References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2014 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Sep 29, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to ΛM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.